These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4126316)

  • 21. Effects of methotrexate and hydroxyurea on psoriatic epidermis. Preferential cytotoxic effects on psoriatic epidermis.
    Smith C; Gelfant S
    Arch Dermatol; 1974 Jul; 110(1):70-2. PubMed ID: 4418706
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
    Gloor M; Graf R; Wirth H; Landau M
    Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plethysmographic recordings of skin pulses. 3. Effect of corticosteroids, dithranol and tar in psoriasis.
    Thune P
    Acta Derm Venereol; 1971; 51(3):183-8. PubMed ID: 4103029
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood vessel changes in psoriatic skin.
    Mottaz JH; Zelickson AS; Thorne EG; Wachs G
    Acta Derm Venereol; 1973; 53(3):195-8. PubMed ID: 4124010
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
    Ernst TM
    Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
    Young MM
    Pharmatherapeutica; 1982; 3(2):86-92. PubMed ID: 7048339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mast cells in skin altered by psoriasis--before, during and after cignolin therapy].
    Schmitz H
    Dermatol Wochenschr; 1967 Mar; 153(9):225-33. PubMed ID: 6082804
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical, histological, ultrastructural and biochemical studies on the effectiveness of hydroxyurea in the treatment of psoriasis].
    Szarmach H; Niczyporuk W; Poniecka H; Kurasz S; Zdrodowska-Stefanow B; Skarzyński J; Wroński A
    Przegl Dermatol; 1981; 68(1):71-8. PubMed ID: 7244263
    [No Abstract]   [Full Text] [Related]  

  • 29. [Abnormal mitochondria--a specific phenomenon of psoriatic keratinocytes?].
    Klug H; Schulze P; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(6):305-7. PubMed ID: 2463184
    [No Abstract]   [Full Text] [Related]  

  • 30. Unusual mitochondrial reaction in psoriatic keratinocytes.
    Klug H; Schulze P
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(3):201-3. PubMed ID: 2906191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Zonal psoriasis].
    da Fonseca A; da Fonseca F
    Med Cutan Ibero Lat Am; 1981; 9(2):139-42. PubMed ID: 6270476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxygen consumption of the germinal epithelium in psoriatic human skin as measured by the Cartesian diver micro-gasometer.
    Hammar H; Hellerström C
    Acta Derm Venereol; 1968; 48(6):563-6. PubMed ID: 4185292
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion.
    Raick AN
    Cancer Res; 1973 Feb; 33(2):269-86. PubMed ID: 4347466
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of cell death and proliferation in psoriatic epidermis.
    Kawashima K; Doi H; Ito Y; Shibata MA; Yoshinaka R; Otsuki Y
    J Dermatol Sci; 2004 Sep; 35(3):207-14. PubMed ID: 15381242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of the epidermis over the histiocytomas in acute psoriatic onset (with observations on the structure of histiocytomas, especially on the behaviot of mast cells)].
    Steigleder GK
    Hautarzt; 1967 May; 18(5):216-8. PubMed ID: 4298282
    [No Abstract]   [Full Text] [Related]  

  • 36. Ultrastructural and biochemical changes induced in mouse epidermis by a hyperplastic agent, ethylphenylpropiolate.
    Raick AN; Burdzy K
    Cancer Res; 1973 Oct; 33(10):2221-30. PubMed ID: 4741928
    [No Abstract]   [Full Text] [Related]  

  • 37. [Structural characteristics of the antipsoriasic drugs chrysarobine and dithranol].
    Krebs A; Schaltegger H
    Hautarzt; 1969 May; 20(5):204-9. PubMed ID: 5354379
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.
    Lauharanta J
    Acta Derm Venereol Suppl (Stockh); 1982; 101():1-29. PubMed ID: 6954822
    [No Abstract]   [Full Text] [Related]  

  • 39. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
    Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Free radicals and the treatment of psoriasis with special reference to dithranol.
    Mustakallio KK; Martinmaa J; Vilvala R; Halmekoski J
    Med Biol; 1984; 62(2):155-8. PubMed ID: 6471937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.